GHRS (GH Research) Other Long-Term Liabilities : $0.00 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is GH Research Other Long-Term Liabilities?

GH Research's other long-term liabilities for the quarter that ended in Mar. 2025 was $0.00 Mil.

GH Research's quarterly other long-term liabilities increased from Sep. 2024 ($-0.00 Mil) to Dec. 2024 ($-0.00 Mil) and increased from Dec. 2024 ($-0.00 Mil) to Mar. 2025 ($0.00 Mil).

GH Research's annual other long-term liabilities increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).

GH Research Other Long-Term Liabilities Historical Data

The historical data trend for GH Research's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Other Long-Term Liabilities Chart

GH Research Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

GH Research Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

GH Research Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

GH Research Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of GH Research's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (NAS:GHRS) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

1KA:Germany

Address

Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95

Website

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.